The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced ...

Early in 2025, scientists discovered a promising new antibiotic in a soil sample from a lab technician's backyard. The ...

Some antibiotics stop bacteria from growing without actually killing them, allowing infections to return later. Scientists at ...

Dealing with an infection isn't as straightforward as simply killing the pathogen. The body also needs to carefully steer and ...

Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, announced plans to unveil the company’s lead candidate at the upcoming Interdisciplinary ...

To address rising threat of antimicrobial resistance, India’s drug regulator plans an overhaul of regulations for antibiotics ...

Bacteria can sneakily evade our best efforts at eradication by developing resistance to various pressures in their ...

A study led by researchers at the Department of Civil Engineering at The University of Hong Kong (HKU) has uncovered alarming ...

Indian cardiac surgeon Dr Devi Shetty says antibiotics may stop working soon and this will take us back to the pre-penicillin ...

Ahmedabad, Union Home Minister Amit Shah on Tuesday said antimicrobial resistance is a "huge threat" to humanity and urged ...

Editorial: Our magic bullets are increasingly rare and ineffective. The golden age of discovery is over and the way we develop and use drugs needs to change ...

The GARDP Foundation and Debiopharm have entered a collaboration and license agreement to pursue the development of a novel, first-in-class antibiotic targeting Neisseria gonorrhoeae.